Johnson & Johnson sales forecast for 2019 misses analysts’ estimates
Healthcare conglomerate is facing increasing competition for some of its older drugs
Drug-maker Merck shares rise following cancer treatment sales
Revenue grows 1% in second quarter to $9.84 billion, beating estimates
Amarin shares slump on FDA panel rejection
Company fails to persuade advisory panel to back exponential expansion of market for cardiovascular drug
YOU MAY ALSO LIKE...
Crosswords & Puzzles
Crosswords & puzzles to keep you challenged and entertained
Election 2024
Full general election coverage including analysis and results for all 43 constituencies
Common Ground
How does a post-Brexit world shape the identity and relationship of these islands
Family NoticesOpens in new window
Weddings, Births, Deaths and other family notices